India's Drugs Regulator Approves Phase-3 Trial of Covid Vaccine Covovax
PTI | Mar 23, 2022, 9:33 PM IST
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28 last year and for inoculating the beneficiaries in the 12-17 years age group, subject to certain conditions, on March 9.










